Related Experiment Video
Updated: Aug 6, 2026
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Limbal-conjunctival autograft transplantation for recurrent pterygium
I Dekaris1, N Gabrić, Z Karaman
1Ophthalmology Department, Lions Croatian Eye Bank, GH Sveti Duh, Zagreb, Croatia. iva.dekaris@eeba.net
Purpose:
To assess the usefulness of limbal-conjunctival autograft transplantation (LCAT) for the treatment of recurrent pterygium.
Patients And Methods:
Seventeen eyes with advanced recurrent pterygium underwent LCAT All had already been treated at least twice either by simple excision (n=15) or by conjunctival rotation autograft (n=2). Three eyes (17.65%) had symblepharon at the time of surgery, so LCAT was combined with amniotic membrane transplantation. The autograft was taken from the supero-lateral part of the same eye and transferred to the area where the pterygium had been excised.
Results:
During 6-18 months of follow-up no postoperative complications occurred. In 15 eyes (88.24%) no pterygium recurrence was recorded; recurrence occurred in two eyes (11.76%) after 8 and 5 months. In three eyes with a combined symblepharon formation, remission of both pterygium and symblepharon growth was obtained.
Conclusions:
LCAT seems to be a promising and safe procedure for recurrent pterygium.
